201 related articles for article (PubMed ID: 9306349)
1. Maintenance cyclosporin monotherapy after renal transplantation--clinical predictors of long-term outcome.
Touchard G; Hauet T; Cogny Van Weydevelt F; Hurault de Ligny B; Peyronnet P; Lebranchu Y; Toupance O; N'Doye P; Busson M
Nephrol Dial Transplant; 1997 Sep; 12(9):1956-60. PubMed ID: 9306349
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting the long-term success of maintenance cyclosporine monotherapy after kidney transplantation.
Hurault de Ligny B; Toupance O; Lavaud S; Bauwens M; Peyronnet P; Le Meur Y; Ryckelynck JP; Jolly D; Leroux-Robert C; Touchard G
Transplantation; 2000 Apr; 69(7):1327-32. PubMed ID: 10798748
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P
Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
[TBL] [Abstract][Full Text] [Related]
6. Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors.
Montagnino G; Tarantino A; Maccario M; Elli A; Cesana B; Ponticelli C
Am J Kidney Dis; 2000 Jun; 35(6):1135-43. PubMed ID: 10845828
[TBL] [Abstract][Full Text] [Related]
7. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
[TBL] [Abstract][Full Text] [Related]
8. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
Grinyó JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J
Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
[TBL] [Abstract][Full Text] [Related]
10. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation.
Hilbrands LB; Hoitsma AJ; Koene KA
Transplantation; 1996 Apr; 61(7):1038-46. PubMed ID: 8623182
[TBL] [Abstract][Full Text] [Related]
11. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin maintenance monotherapy after renal transplantation: what factors predict success?
Touchard G; Verove C; Bridoux F; Bauwens M
BioDrugs; 1999 Aug; 12(2):91-113. PubMed ID: 18031168
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
[TBL] [Abstract][Full Text] [Related]
14. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation.
Sandrini S; Maiorca R; Scolari F; Cancarini G; Setti G; Gaggia P; Cristinelli L; Zubani R; Bonardelli S; Maffeis R; Portolani N; Nodari F; Giulini SM
Transplantation; 2000 May; 69(9):1861-7. PubMed ID: 10830223
[TBL] [Abstract][Full Text] [Related]
16. [Use of mycophenolate mofetil in patients with a transplanted kidney and cyclosporin nephrotoxicity].
Hrvacević R; Ignjatović Lj; Vavić N; Dimitrijević J; Drasković-Pavlović B; Dujić A; Elaković D; Kronja G; Marić M
Vojnosanit Pregl; 2001; 58(2):157-60. PubMed ID: 11475669
[TBL] [Abstract][Full Text] [Related]
17. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?
Marcén R; Pascual J; Teruel JL; Villafruela JJ; Rivera ME; Mampaso F; Burgos FJ; Ortuño J
Transplantation; 2001 Jul; 72(1):57-62. PubMed ID: 11468535
[TBL] [Abstract][Full Text] [Related]
18. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
[TBL] [Abstract][Full Text] [Related]
19. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
[TBL] [Abstract][Full Text] [Related]
20. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants.
Gulanikar AC; MacDonald AS; Sungurtekin U; Belitsky P
Transplantation; 1992 Feb; 53(2):323-8. PubMed ID: 1738926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
